Amdocs Ltd. Hits New 52-Week Low at USD 62.46 Amid Decline

Amdocs has reached a new 52-week low, trading at USD 62.46 as of May 11, 2026. This marks a significant decline for the small-cap company, which operates in the Computers - Software & Consulting industry. Over the past year, Amdocs has experienced a performance drop of 19.17%, contrasting sharply with the S&P 500's gain of 30.97%. The company's market capitalization stands at USD 17,662 million, with a price-to-earnings (P/E) ratio of 28.00. Amdocs has a low debt-to-equity ratio of 0.17, indicating a conservative approach to leverage. Its return on equity (ROE) is reported at 18.45%, reflecting a solid management efficiency. However, the company has faced challenges in long-term growth, with net sales increasing at an annual rate of only 1.68% and operating profit at 7.31% over the last five years. Despite these hurdles, Amdocs maintains a price-to-book ratio of 5.16, suggesting it is trading at a premium compared to its peers. The stock's performance has consistently lagged behind the S&P 500 over the past three years, highlighting ongoing difficulties in achieving market competitiveness.